University Hospital Southampton is implementing Aiforia’s PD-L1 lung cancer AI solution to assess PD-L1 staining in lung cancer specimens. Dr Vipul Foria and Dr Victoria Elliot describe their journey so far.
Rocío de León, the UK Account Manager at Innova-tsn, looks at AI & ML use in the public sector, which is key to the government’s digital transformation.
Dr. Gerardo Fernandez, CSO ViewMind Inc, investigates how early is too early for the detection of Alzheimer’s disease and how soon in the disease’s trajectory detection can make a meaningful difference in a patient’s prognosis.
Mireia Figueras Alsius, Climate Officer at Health Care Without Harm Europe, directs our thoughts towards climate-smart healthcare, including comments on extreme weather events.
Asthma is a chronic inflammatory disease that is characterized by bronchial hyperreactivity (wheezing due to narrowing of the airways) and it disproportionately affects African Americans.
Digital connectivity has ingrained itself into our daily life and is now as crucial to businesses and communities as any other utility. That’s why we must begin to close the digital divide.
Dr Nazneen Rahman, Founder and CEO of YewMaker and Sustainable Medicines Partnership (SMP) Director describes why digital medicine information is essential for sustainable medicines.
Pete Mills, Commercial Technical Operations Manager for Bosch Commercial & Industrial, outlines some of the latest heating technology that could pave the way for net zero in the healthcare sector.
Despite the rising incidence of Central Nervous System diseases worldwide, efficient treatment options for neurological disorders remain scarce. Treatment failures are principally associated with the inability of drugs to pass the highly selective Blood-Brain Barrier rather than a lack of efficacy.
